RussianPatents.com

Diagnostic technique for function-type oddi's sphincter dyssynergia following cholecystectomy

Diagnostic technique for function-type oddi's sphincter dyssynergia following cholecystectomy
IPC classes for russian patent Diagnostic technique for function-type oddi's sphincter dyssynergia following cholecystectomy (RU 2416802):
Another patents in same IPC classes:
Method of predicting duration of recurrence-free period in radically treated patients with mammary gland cancer / 2413231
Content of sex hormones -estradiol and progesterone - in blood is determined. After that coefficient of ratio of estradiol concentration to progesterone concentration is calculated. If values of coefficient are within the range from 10 to 221, duration of recurrence-free period from 5 to 13 years is predicted, and if values of coefficient are within the range 367-1295 recurrence-free period for 28-30 months is predicted.
Method of predicting of process activation in patients with hodgkin's lymphoma / 2405454
Invention relates to medicine, namely to biochemical investigations in oncology, and can be used in determination of activation or stabilisation of pathologic process in patients with primary-resistant Hodgkin's lymphoma. In patients with primary-resistant Hodgkin's lymphoma at stages of treatment, by radioimmune method determined is content in blood of thyroid gland hormones - triiodothyronine and thyroxine, and adrenocortical hormone - cortisol, their concentration is summed up and in case of total level of hormones is within 278.2 nmole/l - 0 333.0 nmole/l conclusion about activation of malignant process is made, if total level of said hormones is 432.4 nmole/l - 833.2 nmole/l conclusion about absence of process activation is made.
Diagnostic technique for severity level of varicocele and its recuring / 2403871
Invention refers to medicine, namely to urology and vascular surgery. The sex hormones level in an involved vein is considered to be a criterion of the severity level of varicocele. There are evaluated the following sex hormones: testosterone, estradiol, progesterone simultaneously in the pampiniform plexus veins of a left ovary and in the peripheral vein of a bend of elbow, with determining the ratio of the sex hormones level in a healthy vein of the bend of elbow to the varicocele-involved pampiniform plexus vein. If said ratio of the sex hormones level is 1:10 to 1:50, the first degree of varicocele is diagnosed. Recurrent varicocele and the second degree of varicocele is diagnosed by the ratio of the sex hormones level in the healthy and involved veins 1:50 to 1:100 times (i.e. hormones concentration in a varicose vein is increased in tens times). If observing the ratio of the sex hormones level in the healthy vein and the involved vein of the pampiniform plexus veins of the left ovary increasing more than in 1:100, the third degree of varicocele is diagnosed. Surgical intervention is indicated if the ratio of the sex hormones level is diagnosed more than 1:50.
Method of bone resorption to remodelling analysis Method of bone resorption to remodelling analysis / 2403870
Invention refers to medicine, namely to biochemistry, surgery and dentistry. The bone resorption to remodeling analysis is based on the biochemical blood examination. An the blood coefficient K1 is calculated by formula: K1=[(PTH:A)+(TNF-α:B)+(IL-1β:C)]:3, where PTH is the parathyroid hormone concentration (pg/ml) in the patients, A is the same value in healthy individuals, TNF-α is the level of tumor necrosis factor -α (pg/ml) in the patients, B is the same value in healthy individuals, IL-1β is the interleukin-1β concentration (pg/ml) in the patients, C is the same value in healthy individuals to derive the blood coefficient K2 by formula: K2=[(calcitonin: D) + (osteocalcin: E)]:2, where the calcitonin concentration (ng/ml) in the patients, D is the same value in healthy individuals, the osteocalcin level (ng/ml) in the patients, E is the same value in healthy individuals. Then the bone metabolism control coefficient (BMCC) is calculated by formula BMCC=K1:K2, and the higher BMCC than 1.17, the more intensive resorption prevails over remodelling; and the lower BMCC than 0.83, the more intensive remodelling prevails over resorption.
Method for assessment of kidney function in felines by measurement of ghrelin hormone levels / 2403573
Method for assessment of kidney function in felines includes determination of observed level of ghrelin in tissue or biofluid of feline and establishment of direct dependence of observed level of ghrelin on kidney function by comparison of observed level of ghrelin with reference level of ghrelin that characterises normal kidney function. Method for diagnostics of kidney disease in felines includes detection of observed level of ghrelin in tissue or biofluid of feline and comparison of observed ghrelin level with referent level of ghrelin, which characterises normal kidney function, where observed level lower than reference level indicates kidney disease or predisposition to it. Method for detection of kidney disease beginning in felines includes monitoring level of ghrelin in tissue or biofluid of feline for a certain period of time; where beginning is identified, if at any moment of time level of ghrelin decreases compared to initial level that characterises healthy kidney function. Diagnostics set includes (a) one or more test materials to detect observed levels of ghrelin in tissue or biofluid of feline; and (b) one or more user-available mediums bearing the following information: (i) reference level of ghrelin that corresponds to a specific feline; and (ii) algorithm of direct dependence of observed ghrelin level relative to reference level on kidney function or reverse dependence of observed ghrelin level relative to reference level on availability of kidney disease or predisposition to kidney disease.
Diagnostic technique for foetal maturity / 2399058
There are determined daily excretion of progesterone metabolite - pregnandiol (Pd), foetal steroids - 16α-hydroxy-ethiocholanolone (16α-OH-Et), 16α-hydroxy-androsterone (16α-OH-An), 16α-hydroxy-dihydroepiandrosterone (16α-OH-DHEA) and oestradiol (Oe) in pregnant women on their 37-42 weeks of pregnancy by capillary gas chromatography. A mature foetus is indicated by the following indices: daily Pd excretion is 150.4-348.3 mcmol/24 hour, 16α-OH-Et - 7.9-16.9 mcmol/24 hour, 16α-OH-An - 6.4-12.6 mkmol/24 hour, 16α-OH-DHEA - 15.4-26.1 mcmol/24 hour, Oe - 24.0-38.7 mcmol/24 hour, while an immature foetus show the indices as follows: daily Pd excretion 80.1-150.2 mcmol/24 hour, 16α-OH-Et - 5.8-7.8 mcmol/24 hour, 16α-OH-An - 4.6-6.3 mcmol/24 hour, 16α-OH-DHEA - 10.2-15.3 mcmol/24 hour, and Oe - 14.5-15.6 mcmol/24 hour, and in a overmature foetus, daily Pd excretion, 16α-OH-Et, 16α-OH-An, 16α-OH-DHEA and Oe are considerably lowered and are less than 50.0 mcmol/24 hour, less than 12.0 mcmol/24 hour, less than 5.8 mcmol/24 hour, less than 4.6 mcmol/24 hour, less than 10.2 mcmol/24 hour, respectively.
Method for prediction of clinical course in disseminated skin melanoma patients / 2399057
Method is implemented by blood analysis for total and free triiodothyronine after the termination of integrated treatment to derive the total to free triiodothyronine ratio, and it is within the range 0.26-0.31, steady state is predicted to be kept in the patients; the ratio within the range 0.19-0.22 ensures to predict the disease generalisation. Technical and economic efficiency of the invention consists in the fact that the derived prognosis factor is an informative laboratory covariant of the favourable or unfavourable development of the pathology.
Method for prediction of effectiveness of neoadjuvant automyelochemotherapy in patients with recurrent breast cancer / 2393484
Prior to begin the therapy, the patient's blood is tested for oestradiol concentration. If the concentration is 18.40 to 29.40 nmol/l, tumour size loss after the neoadjuvant automyelochemotherapy by 67-70% is predicted, that is a partial regress of the tumour, while oestradiol concentration 208.50 to 1541.0 nmol/l enables to predict the tumour size loss by 5-45% that is process stabilisation.
Method for determination severity level of trophological insufficiency in patients with chronic obstructive pulmonary disease / 2390026
Body weight index (BWI) is evaluated; if it is lower than 20 kg/m2, additional analysis is needed to determine the serum leptin concentration. If it is within 16.01±0.64 to 10.15±0.91 ng/ml, the absence of trophological insufficiency is diagnosed, while the values within 5.49±0.46 to 2.26 ng/ml enable to diagnose trophological insufficiency of medium severity, while the values 1.90 to 0.72±0.09 ng/ml indicate severe trophological insufficiency.
Method of forecasting retrocessions of larynx cancer / 2389030
In patients suffering from larynx cancer after surgical oncotomy in the course of dispensary observation levels of androsteron and estradiol in 24-hour collection urine are examined and their ratio to each other are determined. At ratio level more than 3 emergence of disease retrocession or metastasis in the near future is forecasted. At ratio level lower than 3 a long-lasting recurrence-free period is forecasted.
Method for differential diagnostics of mammary diseases in men / 2244308
The present innovation deals with biochemical trials: before the onset of therapy in men one should detect blood content of thyroid hormone - free thyroxine - and at its level being 10.3-12.9 pmol/l one should diagnose mammary cancer, at the level of free throxine being 18.7-31.0 pmol/l - one should predict gynecomastia. The method enables to detect the direction of pathological process and carry out due correction of therapy tactics in men with either gynecomastia or mammary cancer.
Method for predicting the delay of intrauterine fetal development / 2246733
The method deals with studying blood serum of pregnant woman to detect the content of insulin-like growth factor (IGF) and vascular-endothelial growth factor (VEGF) and calculate the coefficient of their ratio: at its value being equal to 28.5 and lower it is possible to diagnose the delay of fetal development.
Method for differential diagnostic of chronic hepatitis and hepatic cirrhosis / 2254577
Thyroglobulin content is determined in blood serum using enzyme immunoassay. When thyroglobulin level is increased by 2 times and more compared in contrast with normal one chronic hepatitis is diagnosed, and when thyroglobulin level is decreased by 1.5-2.5 times in contrast with normal one hepatic cirrhosis is diagnosed.
Method for evaluating combined schizophrenia treatment based on atypical antipsychotic drugs and rations and electroconvulsive shock therapy / 2256181
Method involves determining dehydroepiandrosterone sulfate concentration in blood serum. Its growth above 30% when compared to the initial one being observed, treatment efficiency is determined as negative.
Method for diagnosing obliterated forms of congenital suprarenal gland cortex hyperplasia / 2261447
Method involves applying high effectiveness liquid chromatography for determining cortisol, cortisone 11-deoxycorticosterone, 11-deoxycortisone concentration in blood and free cortisol and free cortisone excretion with urine. Ratios of F/E and FF/FE are calculated, where F is the cortisol level in blood; E is the cortisone level in blood; FF is the free cortisol excretion with urine and FE is the free cortisone excretion with urine. The cortisol level in blood not exceeding norm and at least two of three signs: F/E ratio reduction by 25% and more, FF/FE ratio reduction by 25% and more, free cortisol excretion with urine being equal to 25% and more, obliterated forms of congenital suprarenal gland cortex hyperplasia is diagnosed. Corticosterone level in blood growing by 50% and higher, 21-hydroxylase defect is considered to be the case. 11-deoxycorticosterone and/or 11-deoxycortisone concentration in blood being et or greater than 50%, 11β-hydroxylase defect is considered to be the case.
Method for diagnosing atrophic gastritis cases Method for diagnosing atrophic gastritis cases / 2262706
Method involves making pepsinogen 1, gastrin and Helicopter pylori infection marker combinations analysis and making input of the obtained results into data processing means comprising operation system, means for receiving, transmitting and processing data. The mentioned data processing means is usable for comparing the measured concentration value of a substance under study to a threshold value associated to the substance under study and producing information as a response to comparison results and additionally to other entered data. A set and software are used for implementing the method.
Method for predicting relapse of mammary cancer / 2263319
In the course of surveying in menopausal women after complex therapy one should state the development of mammary cancer at decreased ratio of estriol concentration to the sum of estrone and estradiol urinary concentrations from 1.68±0.23 in relapse-free patients up to 0.74±0.12 - in patients living without relapses for less than a year, up to 0.65±0.13 in patients living without relapse from 2 up to 6 years and up to 0.50±0.10 in patients with relapse-free period from 6 to 10 years. The innovation provides pre-clinical detection of mammary cancer relapse.
Method for predicting fetoplacental insufficiency in pregnant women with thyroid diseases / 2263919
Except detecting placental lactogen in blood serum one should study the content of alphafetoprotein. At placental lactogen content being below 75% against the norm and content of alphafetoprotein below 70% against the norm it is possible to conclude upon availability of fetoplacental insufficiency.
Method for predicting cholecystitis and cholelithiasis / 2263920
While diagnosing cholecystitis and cholelithiasis due to ultrasound testing one should additionally study blood plasma and bile to detect there the content of prostaglandins PGE2 and PGF2α. At PGE2/PGF2α ratio in blood plasma being equal to 6 and more, and, also, at decreased level of biliary cholecystokinin-pancreosimin by 38% and more, biliary PGE2 by 59% and more and increased level of biliary prostaglandin PGF2α by 5.9 times and more against the norm one should diagnose chlecystitis and cholelithiasis. The innovation enables to detect the above-mentioned diseases at earlier stage.
Method for predicting powerless labor in pregnant nodular goiter surgically treated on goiter occasion during pregnancy under medical supervision / 2273456
Method involves determining thyroid gland node diameter and thyrotropic hormone by applying ultrasonic examination approach. Histological examination is carried out with conclusion concerning morphologic nature being obtained like nodular colloid proliferating goiter or thyroid gland adenoma. Diagnostic index Σ is calculated from formula Σ=0.49*K1+0.07*K2-0.5*K3+1.76*K4-1.53, where K1 is the thyroid gland node diameter; K2 is the TTH concentration; K3 is the nodular colloid proliferating goiter index equal to 1 or 0; K4 is the thyroid gland adenoma index equal to 1 or 0. Diagnostic index Σ being less than zero, conclusions concerning powerless labor threat is to be drawn.

FIELD: medicine.

SUBSTANCE: cholecystokinin level is counted additionally in the patients with post-cholecystectomy syndrome. In case the concentration is below 0.5 ng/ml, and while observing no organic pathology of hepatopancreatoduodenal organs as demonstrated by instrument methods, function-type Oddi's sphincter dyssynergia is diagnosed.

EFFECT: use of the technique allows early diagnosing function-type Oddi's sphincter dyssynergia following cholecystectomy.

1 dwg, 2 ex

 

The invention relates to medicine, can be used in surgery and gastroenterology.

Applied research methods, such as ultrasonography (USG) agencies typical for hepatic-pancreaticoduodenal area (GPDS), computed tomography, fibroesofagogastroduodenoscopia (peggs), endoscopic retrograde retrograde cholangiopancreatography (ERCP), duodenoscope inspection of the mouth of the large duodenal papilla (LDP) and manometry of the sphincter of Oddi (SO), allow to identify organic changes of the large duodenal papilla [1]. Remains unresolved the question of the establishment of functional disorders of motility of the sphincter of Oddi.

In addition, these diagnostic methods, as ERCP [2, 3], duodenoscope inspection of the mouth of the LDP and manometry WITH [4], require special equipment, availability of highly skilled specialist, traumatic, after these manipulations the high risk of complications (acute pancreatitis, pancreatic necrosis, stricture MDP) and may not be used as a screening.

From non-invasive methods of investigation in the clinic applies dynamic ultrasonography biliary tract and pancreatic duct with the assessment of contractility of the sphincter of Oddi. But this method is not sufficiently informative [5, 6]. When ultrasonography is possible to estimate the diameter of the duct (choledochal Wirsung duct occured), but to assess contractility, especially when there is a spasm, not stenosis of the sphincter of Oddi, is almost impossible. More reliable results may be obtained when assessing contractile function WITH (the functional nature of the violations) with the drug load (neostigmine, sorbitol, atropine, procaine) [7]. But if you are hypersensitive method is not applicable.

There is a method of determining the dyskinesia of the gallbladder and sphincter of Oddi by duodenal intubation by assessing the duration of stage gallbladder bile and voltage biliary excretion [8]. The disadvantages of this method are the invasiveness, duration of the study and the inability to perform a method in a Department emergency surgery.

There is a method of differential diagnosis of dysfunction of the sphincter of Oddi (DSO) organic and functional nature of using ultrasonography to change the diameter of the choledochus when performing relaxation isosorbide dinitrate treatment in combination with food stress [9]. As well as the method of assessing the functional state of the biliary system in patients after cholecystectomy by ultrasonic measurement of the diameter supraduodenal Department of choledochus and diameter intrapancreatic division of the common bile duct and calculation of the index emptying the lobby of the Okha and subsequent pharmacological tests metoclopramide and repeated ultrasound scanning [10].

The disadvantages of these methods is the presence of individual intolerance to the drugs necessary for carrying out the manipulation, and the likelihood of complications after medical and food provocation in the presence of organic obstacles to biliar flow-out.

In the case when in the course of screening and qualifying diagnostic measures establish violations of organic nature, directly or indirectly associated with the DSO (stenosis CD, stricture CD, papilla, residual or recurrent choledocholithiasis and so on), therapeutic management unambiguous and clear. But, when the cause of pain and dyspepsia after the whole set of diagnostic events cannot be established, no detectable organic pathology of hpda organs and comorbidities, capable of simulating the basic pathology, it is necessary to talk about the DSO functional type.

There are several theories of the development of the DSO functional type after cholecystectomy.

According to one of them, after removal of the gall bladder is a decrease in the sensitivity of the receptors of the sphincter of Oddi to cholecystokinin (CCK), increases the tone of the sphincter in response to food stimulation occurs biliary and/or pancreatic hypertension and attack of abdominal pain [11].

According to another theory, after cholecystectomy in a different time,which is determined individually by the compensatory abilities of the body, change the number produced by CCK [12].

The clinic does not apply valuation methods cholecystokinin level before surgery and after cholecystectomy for establishing unclear the cause of pain and dyspepsia.

The objective of the invention is to increase the objectivity of early diagnosis of dysfunction of the sphincter of Oddi function type after cholecystectomy.

The task to solve due to the fact that in patients with postcholecystectomy syndrome additionally determine the level of cholecystokinin and at concentrations below 0.5 ng/ml, and in the absence of organic pathology of hpda organs on the results of instrumental methods of examination - diagnose dysfunction of the sphincter of Oddi function type.

The concentration of CCK<0.5 ng/ml indirectly indicates the presence of hypertonic sphincter apparatus biliary system, including the sphincter of Oddi. And when combining this indicator with characteristic clinical manifestations, changes of biochemical parameters of blood during the attack, the absence of organic pathology (by ultrasound (US) and fibroesofagogastroduodenoscopia (peggs)) indicates the presence of DSO functional nature.

The method is as follows: all patients diagnosed with post-cholecystectomy syndrome in on what tuplenie conduct complex clinical (complaints, medical history, personal history, physical examination), laboratory (full blood count, urinalysis, blood chemistry, blood glucose level) and instrumental (ultrasonography of the abdominal cavity and retroperitoneal space, fibroesofagogastroduodenoscopia, electrocardiography, chest x-ray) examination to exclude comorbidities, according to testimony - consultation of specialized professionals. Additionally assess the level of cholecystokinin plasma by ELISA for determination of cholecystokinin with stage inactivated (an enzyme Immunoassay for the determination of the peptide with the stage inactivated (Peninsula Laboratories Inc, USA). In the samples (blood plasma) determine the concentration of cholecystokinin (ng/ml). The normal level of cholecystokin ranges from 0.5 to 1 ng/ml [11]. The time of denition of the level of CCK - 5.5 hours. When the level of CCK below 0.5 ng/ml, and in the absence of organic pathology of hpda organs on the results of instrumental methods of examination - diagnose dysfunction of the sphincter of Oddi function type.

The sample of 89 patients of both sexes with postcholecystectomy syndrome (PAS) aged 25 to 80 years.

The average age was - 52,5±1 year.

The study included 69 (77.5%of women and 20 (22.5 percent)men with pain and dyspeptic phenomena - with PHAS functional types at different times after cholecystectomy (HAE), made of an open, minilaparotomy and video-assisted laparascopic accesses.

Runtime HAE varied within wide limits. In the period up to 1 month were delivered 14 (16%) patients, from 1 to 3 months - 9 (10%), from 3 to 6 months - 16 (18%), from 6 months to 1 year - 11 (12%), from 1 year to 5 years - 17 (19%) and in terms of more than 5 years - 22 (25%) of the patients.

For complex examination of patients not detected organic pathology from GPDS. Upon receipt they complained of abdominal pain in biliary or pancreatic type, nausea, dry mouth, some marked by vomiting of bile, bringing relief, diarrhea or constipation.

Blood sampling of patients was performed once at admission before treatment.

Blood was taken in the amount of 9 ml and placed in a polypropylene tube containing ethylenediaminetetraacetic acid (EDTA) (1 mg/ml blood) and Aprotinin (500 Ked/ml of blood), centrifuged at 1600 rpm for 15 minutes. The plasma was transferred to a new polypropylene tube. For maximum stability was stored at -70°C. the Study of the level of CCK was performed using an immunoassay kit for determining peptide with extraction separation columns C18 Sep (Peninsula Laboratories Inc, USA). The calculation result is s carried out automatically on the device Universal Microplate Reader ELx 800 (BIO-TEK INSTRUMENTS INC) by placing in the apparatus of the tablet and calculate the optical density at a wavelength of 450 nm. Automatically calculates the concentration of a calibration curve. The result was represented in digital form. Unit - ng/ml.

The control group was 15 healthy donors without pathology of hpda organs. The average concentration of CCK in the control group was 0.57±0,023 ng/ml.

In the study of the concentration of CCK in patients with PAS showed a trend of lower levels of CCK. In the period up to 1 month after surgery, the average level of CCK remains at the lower limit of normal (0,58±0.05 ng/ml), in terms of 1 to 3 months - 0,22±0.02 ng/ml, from 3 to 6 months to 0.14±0,009 ng/ml, in terms from 6 months to 1 year from 1 year to 5 years varies in the range of 0.16±0,005 - 0,1±0,002 ng/ml, more than 5 years - 0,08±0,008 ng/ml Thus, the level of CCK after gallbladder removal bubble has a progressive tendency to decrease. The drawing shows the concentration of CCK in plasma of patients with clinical manifestations of the DSO functional types at different times after cholecystectomy (n=89), where the vertical is indicated concentrations of CCK (ng/ml), across - the period of time after surgery, which was performed blood sampling:

1 - up to 1 month;

2 - from 1 to 3 months;

3 - from 3 to 6 months;

4 - 6 months to 1 year;

5 - from 1 year to 5 years;

6 - more than 5 years.

Thus, already in the first month after HE neuropeptide link reacts to new conditions b is larnage tract by reducing the level of CCK in the absence of the main target of action of CCK - bile pusara.

Example 1.

Patient K., 51, was taken to the XO-I GKB №7 07.02.2009 by ambulance with a presumptive diagnosis: post-cholecystectomy syndrome, acute pancreatitis.

At admission the patient complained of pain in the epigastrium and left hypochondrium, nausea, single vomiting bile, dry mouth. Pain in acute about 24 hours ago after errors in diet (intake of fatty foods).

From the anamnesis of life: hepatitis, tuberculosis, diabetes, cancer, sexually transmitted diseases denies. Injury, blood transfusion was not. Underwent a laparoscopic cholecystectomy 3 months ago. Allergic anamnesis is not burdened.

Objectively: the patient's state of moderate severity. Clear consciousness. The active position. The body temperature to 36.8°C. the Skin and visible mucous usual coloration and humidity. Visible pathology of bone and joint system. The vesicular breathing, is all lung fields, no wheezing. The NPV of 16 per minute. Cor tones clear, rhythmic. HR=Ps=76 per minute. HELL 140/90 mm Hg Language moist, moderately white furred. Abdomen normal configuration, symmetrical, evenly participates in the act of breathing, palpation painful, moderately intense in the epigastrium and left hypochondrium. Symptoms carte, Cochrance positive. But the ohms of peritoneal irritation no. Symptom XII ribs negative on both sides. The chair was in the morning, decorated. Dysuria is not.

Data on laboratory studies: hemoglobin 128 g/l, erythrocytes of 3.9×109/l, leukocyte count of 8.2×109/l, band 1, segmented 69, lymphocytes 18, monocytes 12; glucose 4.3 mmol/l; bilirubin total of 12.0 mmol/l, direct-4.5 mmol/l, indirect 7.5 µmol/l, amylase 8.2 mg/s×l, urea of 4.9 mmol/l, total protein and 70.5 g/l, Alt of 0.65 mmol/h×l, AST 0.27 mmol/h×L.

The level of CCK plasma - 0.15 ng/ml.

Data instrumental methods: ultrasonography of the abdominal cavity and retroperitoneal space - after cholecystectomy. Diffuse changes in the pancreas. Choledoch - 7 mm Biliary hypertension no. Kidney - without a pathology. Fibroesofagogastroduodenoscopia - atrophic gastritis. Electrocardiography - alone without pathology. Chest x-ray from the side of the lungs and heart age-related changes.

Confirmed diagnosis of postcholecystectomy syndrome. Dysfunction of the sphincter of Oddi functional type (level of CCK - 0.15 ng/ml).

Prescribed conservative treatment: intravenous infusion of glucose-procaine mixture, antispasmodic drugs (according to the standard scheme) and mebeverine hydrochloride 1 capsule (200 mg) 4 times a day orally for 9 days.

Amid conservativegreen the patient's condition has improved - pain syndrome and dyspepsia cropped. Jaundice no. Body temperature is normal.

The patient was discharged on the 9th day in a satisfactory condition with no complaints with the recommendations of diet and receiving selective spasmolytic drugs: mebeverine hydrochloride 1 capsule (200 mg) 4 times a day orally for 14 days after discharge from hospital and in the event of such pain.

Example 2.

Patient K., aged 65, was delivered in XO-I GKB №7 28.12.2008 by ambulance with a presumptive diagnosis: post-cholecystectomy syndrome, acute pancreatitis.

At admission the patient complained of pain in the epigastrium and left hypochondrium, nausea, double vomiting food mixed with bile, neprinosâŝego relief, dryness in the mouth. Ill acutely about 12 hours ago, after errors in diet (alcohol and fatty foods).

From the anamnesis of life: hepatitis, tuberculosis, diabetes, cancer, sexually transmitted diseases denies. Injury, blood transfusion was not. Suffering from hypertension. Underwent cholecystectomy from mini-access 5 months ago. Allergic anamnesis is not burdened.

Objectively: the patient's state of moderate severity. Clear consciousness. The active position. The body temperature of 36.2°C. the Skin and visible mucous regular color and is laineste. Visible pathology of bone and joint system. The vesicular breathing, is all lung fields, no wheezing. The NPV of 20 per minute. Cor tones clear, rhythmic. HR=Ps=87 per minute. HELL 150/100 mm Hg Tongue moist, coated with white bloom. Abdomen normal configuration, symmetrical, evenly participates in the act of breathing, palpation painful, moderately intense in the epigastrium and left hypochondrium. Symptoms carte, Cochrance positive. Symptoms of peritoneal irritation no. Symptom XII ribs negative on both sides. The chair was last night, decorated. Dysuria is not.

Data on laboratory studies: hemoglobin 162 g/l, erythrocytes of 4.9×109/l, leukocyte count of 7.8×109/l, stab 3, segmented 71, lymphocytes 22, monocytes 4; glucose 4.0 mmol/l; total bilirubin 19.0 µmol/l, direct-5.0 mmol/l, indirect 14.0 µmol/l, amylase 7,0 mg/×l, urea of 6.9 mmol/l, total protein of 67.5 g/l, Alt 0.84 mmol/h×l, AST of 0.56 mmol/h×L.

The level of CCK plasma - 0.22 ng/ml.

Data instrumental methods: ultrasonography of the abdominal cavity and retroperitoneal space - after cholecystectomy. Diffuse changes in the pancreas. Choledoch - 6 mm Biliary hypertension no. Kidney - without a pathology.

Fibroesofagogastroduodenoscopia - atrophic gastritis, duodenitis. Electracard ografia - signs of left ventricular hypertrophy. Chest x-ray from the side of the lungs and heart age-related changes.

Confirmed diagnosis of postcholecystectomy syndrome. Dysfunction of the sphincter of Oddi functional type (level of CCK plasma - 0.22 ng/ml).

Prescribed conservative treatment: intravenous infusion of glucose-procaine mixture, antispasmodic drugs (according to the standard scheme) and mebeverine hydrochloride 1 capsule (200 mg) 4 times a day orally for 9 days.

On the background of conservative treatment the patient's condition improved, the pain and dyspepsia cropped. Jaundice no. Body temperature is normal.

The patient was discharged on the 9th day in a satisfactory condition with no complaints with the recommendations of diet and receiving selective spasmolytic drugs: mebeverine hydrochloride 1 capsule (200 mg) 4 times a day orally for 14 days after discharge from hospital and in the event of such pain.

The advantages of the proposed diagnostic method is its novelty, the rapidity of results (reaction time of 5.5 hours and informative, so you can use it for a comprehensive diagnosis of the dysfunction of the sphincter of Oddi after cholecystectomy in the early stages.

Literature

1. Endoscopy of the digestive tract / Weatherbe, the.Isolates, Smobc and others - M.: Triad-Pharm, 2002. - 176 S.

2. Diagnosis and treatment of postcholecystectomy syndrome / Vchost.exe, Viesnik, Idenity etc. // Surgery. - 1989. No. 7. - P.8-14.

3. Zhegalov PS Endoscopic retrograde retrograde cholangiopancreatography in the diagnosis and treatment of postcholecystectomy syndrome / Psiholog, Usenik, Dwikardana // Endoscopic surgery. - 2006. No. 2. P.47 - 48.

4. Eagles HE Study of the functional state of the sphincter of Oddi using endoscopic papillosphincterotomy / Swellow // Honey. help. - 1995. No. 2. - P.23-26.

5. Dergachev YA radiology of the biliary system before laparoscopic cholecystectomy. Division I: Ultrasonic methods / Ayadurai, Arebrowse // Vestnik St.Petersburg University. roentgenology and radiology. - 2000. No. 2. - P.55-64.

6. Dalakov I.G. Comprehensive prevention and prediction of the true postcholecystectomy syndrome in surgery for acute cholecystitis in patients of elderly and senile age: author. dis.... Kida. the honey. Sciences / Igudala. - Stavropol, 2007. - 22 S.

7. Chikishev IV Diagnosis and treatment of postcholecystectomy syndrome: author. dis.... Kida. the honey. Sciences / Ivicicova. - Krasnoyarsk, 2007. - 28 S.

8. RF application (A) NO. 2007124172, AV 5/00, bull. No. 1, 10.01.2009,

9. RF patent №2245102, AV 8/00, bull. No. 3, 27.01.2005,

10. RF patent №2283032, AV 8/00, bull. No. 25, 10.09.2006,

11. Tkachenko E.V. the Role of prostaglandins and constitutional hormones in the pathogenesis of chronic diseases hepatobiliary system: author. of thesis ... Dr. med. Sciences / Avichina. - M., 2006. - 48 S.

12. Stewart, L. Spectrum of gallstone disease in the veterans population // L.Stewart, J.M.Griffiss, L.W.Way // Am. J. Surg. - 2005. - V.190, No. 5. - P.746-751.

Method for the diagnosis of dysfunction of the sphincter of Oddi function type after cholecystectomy, including laboratory testing of blood plasma, characterized in that it further determine the level of cholecystokinin and when the values of its concentration below 0.5 ng/ml, and in the absence of organic pathology of organs typical for hepatic-pancreaticoduodenal area according to the results of instrumental methods of examination diagnose dysfunction of the sphincter of Oddi functional type.

 

© 2013-2015 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.